3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Colorectal Neoplasms
2
COVID-19
2
Breast Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Spondylitis, Ankylosing
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Lupus Erythematosus, Systemic
1
Inflammatory Bowel Diseases
1
Hypogonadism
1
Head and Neck Neoplasms
1
HIV Infections
1
Death
1
Crohn Disease
1
Colitis, Ulcerative
1
Interventions
Cyclophosphamide
11
fludarabine
6
Vincristine
4
Rituximab
4
Doxorubicin
4
zanubrutinib
3
Prednisone
3
pirtobrutinib
2
cemiplimab
2
acalabrutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Leukapheresis
2
Immunotherapy, Adoptive
2
Etoposide
2
Dexamethasone
2
Cell- and Tissue-Based Therapy
2
tafasitamab
1
sodium-iodide symporter
1
selinexor
1
ruxolitinib
1
pomalidomide
1
polatuzumab vedotin
1
obinutuzumab
1
ibrutinib
1
glofitamab
1
etoposide phosphate
1
blinatumomab
1
X-Rays
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.